Vir Biotechnology
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $3,075 | $56,376 | $16,787 | $-4,098 |
Gross Profit | -1,237 | 51,800 | 11,510 | -4,136 |
EBITDA | -125,105 | -47,964 | -112,637 | -184,025 |
EBIT | -129,365 | -52,481 | -117,116 | -190,428 |
Net Income | -138,378 | -65,275 | -115,973 | -163,413 |
Net Change In Cash | 3,075 | 56,376 | 16,787 | -4,098 |
Free Cash Flow | -78,513 | -111,262 | -109,462 | -159,543 |
Cash | 310,810 | 174,046 | 254,844 | 452,100 |
Basic Shares | 136,233 | 135,280 | 134,608 | 134,289 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $86,180 | $1,580,472 | $1,087,068 | $76,368 |
Gross Profit | 63,964 | 1,434,153 | 1,021,203 | 76,368 |
EBITDA | -641,554 | 944,208 | 282,702 | 514,328 |
EBIT | -661,005 | 928,716 | 270,719 | -298,719 |
Net Income | -615,061 | 515,837 | 528,584 | -298,665 |
Net Change In Cash | 86,180 | 1,580,472 | 1,087,068 | 76,368 |
Cost of Revenue | -88,072 | 328,671 | ||
Free Cash Flow | -800,358 | 1,595,225 | -69,406 | -197,490 |
Cash | 254,844 | 848,631 | 347,815 | 436,575 |
Basic Shares | 134,130 | 134,810 | 133,437 | 119,159 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$1.56 |
2024-06-30 | -$1.02 |
2024-03-31 | -$0.48 |
2023-12-31 | -$0.86 |
